AndersohnF, SchmedtN, WeinmannS, et al.Priapism associated with antipsychotics: Role of Α1 adrenoceptor affinity. J Clin Psychopharmacol, 2010; 30(1):68–71; doi: 10.1097/JCP.0b013e3181c8273d
2.
BrichartN, DelavierreD, PeneauM, et al.Priapism associated with antipsychotic medications: A series of four patients. Progres En Urologıe, 2008; 18(10).
3.
NaranjoCA, BustoU, SellersEM, et al.A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 1981; 30(2):239–245; doi: 10.1038/clpt.1981.154
4.
SoodS, JamesW, BailonMJ. Priapism associated with atypical antipsychotic medications: A review. Int Clin Psychopharmacol, 2008; 23(1):9–17; doi: 10.1097/YIC.0b013e3282f1c1ef
5.
YoshidaK, MüllerDJ. Pharmacogenetics of antipsychotic drug treatment: Update and clinical ımplications. Mol Neuropsychiatry, 2020; 5(Suppl. 1):1–26; doi: 10.1159/000492332